Article
Molecular basis for the mechanism of action of an anti-TACE antibody
9 Sept 2016
Abstract excerpt
Inhibitors of tumor necrosis factor-α converting enzyme (TACE) have potential as therapeutics for various diseases. Many small molecule inhibitors, however, exhibit poor specificity profiles because they target the highly conserved catalytic cleft of TACE. We report for the first time the molecular interaction of a highly specific anti-TACE antagonistic antibody (MEDI3622). We characterized the binding of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
